Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp15 | Adrenal Case reports | ECE2018

Etomidate for the management of severe hypercortisolaemia in different clinical scenarios – a case series

Lebek-Szatanska Agnieszka , Nowak Karolina M , Zgliczynski Wojciech , Papierska Lucyna

Cushing’s syndrome is associated with life-threatening complications, as well as high rates of perioperative mortality and morbidity. Authors present clinical scenarios, in which one should consider the usage of intravenous etomidate as an accurate, safe and effective drug for hypercortisolaemia.Case 1: 23-year-old female with severe Cushing’s syndrome due to metastatic adrenocortical carcinoma was admitted to the Department of Endocrinology. S...

ea0073aep325 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Association of glucocorticoid receptor gene polymorphism A3669G (9β) with lower glucose concentration 2 hours after OGTT in patients during chronic glucocorticoid treatment

Nowak Karolina , Sobalska-Kwapis Marta , Zgliczynski Wojciech , Papierska Lucyna

Background2–3% of the general population is chronically treated with glucocorticoids (GCs). Modification of the structure and/or function of the glucocorticoid receptor (GR) due to its polymorphisms may result in increased (GC – S – bclI, N363S) or decreased (GC – I – A3669G, ER22/23EK) sensitivity to GCs. To date, whether such modulation of cell’s response to GCs can be associated with presence or absence of the side effect...

ea0067gp17 | Poster Presentations | EYES2019

Etomidate as a treatment option in severe ACTH-dependent (ectopic) Cushing syndrome

Nowak Karolina M , Łebek-Szatańska Agnieszka , Papierska Lucyna

Background: Etomidate is mainly used in general anesthesia. In some rare cases it can also be helpful in treating life-thretening severe hypercortisolaemia (in much lower doses) in patients who are not able to take oral medications or when oral drugs are not available.Case Presentation: Fifty-seven-year-old woman with symptoms of virilization, hypokalemia and muscle weekness for 6 months was admitted to Department of Endocrinology. On admission cortisol ...

ea0049ep469 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Evaluation of oral glucose tolerance test as a screening test detecting glucose metabolism impairment in patients chronically treated with glucocorticoids without previous history of diabetes

Nowak Karolina , Romanowska-Prochnicka Katarzyna , Bornikowska Katarzyna , Zgliczynski Wojciech , Papierska Lucyna

Introduction: One of the most common side effects of glucocorticoid treatment is glucose intolerance and diabetes. Although glucocorticoids cause mainly postprandial hyperglycaemia the International Diabetes Federation, American Diabetes Association and The European League Against Rheumatism recommend to screen patients chronically treated with glucocorticoids by regularly determining fasting plasma glucose. Such an approach can lead to false negative results. Since pre-diabet...

ea0041ep593 | Endocrine tumours and neoplasia | ECE2016

Prognostic factors of recurrence-free and overall survival in 52 patients with adrenocortical carcinoma

Nowak Karolina M. , Samsel Radoslaw , Cichocki Andrzej , Roszkowska-Purska Katarzyna , Kasperlik-Zaluska Anna , Papierska Lucyna

Adrenocortical carcinoma (ACC) is a rare and very aggressive tumor with poor prognosis. The aim of the study was to identify prognostic factors of recurrence-free (RFS) and overall survival (OS) in patients with ACC.We present a retrospective analysis in 52 patients diagnosed with ACC. A number of factors both histological and clinical were analyzed. Recurrent disease was defined as a new lesion confirmed in imaging. Kaplan-Meier method and multivariate ...

ea0041ep637 | Endocrine tumours and neoplasia | ECE2016

Analogues of somatostatin in preoperative treatment of rare NET

Papierska Lucyna , Nowak Karolina , Rabijewski Michał , Ćwikła Jarosław

Analogues of somatostatin are widely used in management of neuroendocrine tumors. The “classic” indications for this treatment are: acromegaly and NETs of midgut to diminish symptoms caused by hormonal overproduction and slow down the tumors’ growth. However we consider the use of this medication also in the other cases in which we confirm the presence of somatostatin receptors in tumor by somatostatin receptor scintigraphy.We would like t...

ea0041ep678 | Female Reproduction | ECE2016

The influence of insulin resistance on selected anthropometric and biochemical parameters in women with Polycystic Ovary Syndrome- preliminary report

Bronczyk-Puzon Anna , Kulik-Kupka Karolina , Nowak Justyna , Koszowska Aneta , Zubelewicz-Szkodzinska Barbara

Introduction: Polycystic Ovary Syndrome is the most common recognized endocrinopathy in women. The syndrome is often accompanied by obesity and insulin resistance.Aim: The aim of the study was to assess the differences between the selected anthropometric and biochemical parameters in a group of women with insulin resistance and without insulin resistance.Materials and methods: The study included a group of 45 women diagnosed with P...

ea0037ep178 | Reproduction, endocrine disruptors and signalling | ECE2015

Visceral adiposity index – new anthropometric marker in women with polycystic ovary syndrome: preliminary reports

Bronczyk-Puzon Anna , Jagielski Pawel , Kulik-Kupka Karolina , Nowak Justyna , Koszowska Aneta , Zubelewicz-Szkodzinska Barbara

Introduction: Early detection of carbohydrate and fat metabolism disorders in women with polycystic ovary syndrome allows the early prevention of cardiovascular diseases and type II diabetes.Aim: The purpose of this study was to assess the selected metabolic indicators and anthropometric measurements in two groups of women: metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy PCOS (MU-PCOS).Material...

ea0070aep99 | Adrenal and Cardiovascular Endocrinology | ECE2020

Assessment of serum adropin concentrations in primary aldosteronism

Łebek-Szatańska Agnieszka , Glinicki Piotr , Nowak Karolina , Zgliczynski Wojciech , Papierska Lucyna

Background: Primary aldosteronism constitutes the most common form of hormonal hypertension. However, it is often mistreated and widely underdiagnosed. Despite the great progress in laboratory technics of adrenal diseases, in the field of primary aldosteronism there is still a need for novel biomarkers that would clarify the diagnosis in equivocal cases. Adropin is a newly discovered protein that may play a role in glucose metabolism and the development of cardiovascular disea...

ea0070ep47 | Adrenal and Cardiovascular Endocrinology | ECE2020

Normotensive primary aldosteronism in a young woman taking minipill – case report

Łebek-Szatańska Agnieszka , Nowak Karolina , Zgliczynski Wojciech , Papierska Lucyna

Background: Primary aldosteronism (PA) is the most frequent cause of hormonal hypertension, typically associated with hypokalaemia. Whereas hypertension with no hypokalaemia can be present in even half of cases, hypokaleamia in normotensive patients is a very rare finding. Mechanisms that act against developing hypertension despite aldosterone excess are at least a few. Some patients with previous low blood pressure increase its values because of hyperaldosteronism, thus still...